DayTwo offers a sustainable path to remission for metabolic disease (diabetes, prediabetes, clinical obesity, non-alcoholic fatty liver disease) that uses gut microbiome sequencing, artificial intelligence, and virtual care.After 10 years of scientific research, and the development of an AI-based algorithm that predicts blood sugar response to food, DayTwo’s virtual care solution reduces or eliminates medications by improving Time in Range and lowering A1C.
Tags
Total Employees
68
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!